Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

886290

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Negligence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the coming into force of the Preparation and Dispensing Errors (Registered Pharmacies) Order 2018 of the risk of pharmacists being prosecuted as a result of an inadvertent dispensing error.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	136485
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>There have been very few prosecutions in regard to preparation and dispensing errors made by pharmacists to date, and we expect the number to reduce even further. The fundamental premise on which this Order is based is that new defences for offences concerning dispensing errors will reduce the risk of prosecution, leading to an increase in the number of reported errors. Over time, learning from increased numbers of error reports is expected to lead to improvements in training and practices, which should reduce the number of errors made.</p><p> </p><p>An Impact Assessment, published alongside the Order, records that there have only been three prosecutions by the Medicines and Healthcare products Regulatory Agency since 2003 and a similarly very low number by the Crown Prosecution Service and the Public Prosecution Service for Northern Ireland. No specific figure was given for the likely number of prosecutions in future, either for prosecution for the offences to which the defences relate or under the general criminal law. However, the Impact Assessment did seek to put a monetary value on the benefit from a reduced risk of prosecution and estimated a benefit to business of £565,770. The consultation responses supported this part of the analysis.</p><p> </p><p>Whilst it is estimated this policy will result in a reduced risk of prosecution, in the most serious cases, for example where a dispensing error leads to the death of a patient, prosecution will continue to be possible under the general criminal law – for example for gross negligence manslaughter.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:15:07 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

825425

registered interest
date	18/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the General Pharmaceutical Council's enforcement of standards for registered pharmacy premises; whether he has made an assessment of the effect of failure to apply such standards to pharmacy owners rather than only pharmacy professionals on the safety of patients; and if he will make a statement.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123566
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The Department has not made any assessment of the effectiveness of the General Pharmaceutical Council (GPhC) as a regulator of pharmacy professionals and pharmacy premises. The Professional Standards Authority, which in its review of the GPhC’s performance in 2016-2017, found that the GPhC had met all of the standards for good regulation, including all of the standards for fitness to practise.</p><p> </p><p>Standards to safeguard the health, safety and wellbeing of patients and the public are set by the GPhC. It is important to note that there are very different legal frameworks for upholding these standards and how the regulator deals with these for pharmacy premises as compared to pharmacy professionals. 87% of the pharmacies inspected by the GPhC in 2016-17 were meeting all of the standards it sets. Any pharmacy not achieving all of the standards is required by the GPhC to implement an action plan to improve the services they provide. In this period the GPhC agreed 469 action plans with pharmacies to ensure they improved the services they provide, and 99% of them made the necessary improvements so that they were meeting all of the standards. In the same period 140 cases were made affecting an individual pharmacy professional’s registration.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 123567 question first answered 23/01/2018 17:21:47 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

825426

registered interest
date	18/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the failure to apply sanctions for standards for pharmacy premises has resulted in a disproportionate number of individual pharmacist registrants who have been held to account for professional standards which may have been impacted by the working environment created by pharmacy owners; and if he will make a statement.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123567
answer	answer is ministerial correction date of answer 23/01/2018 answer text <p>The Department has not made any assessment of the effectiveness of the General Pharmaceutical Council (GPhC) as a regulator of pharmacy professionals and pharmacy premises. The Professional Standards Authority, which in its review of the GPhC’s performance in 2016-2017, found that the GPhC had met all of the standards for good regulation, including all of the standards for fitness to practise.</p><p> </p><p>Standards to safeguard the health, safety and wellbeing of patients and the public are set by the GPhC. It is important to note that there are very different legal frameworks for upholding these standards and how the regulator deals with these for pharmacy premises as compared to pharmacy professionals. 87% of the pharmacies inspected by the GPhC in 2016-17 were meeting all of the standards it sets. Any pharmacy not achieving all of the standards is required by the GPhC to implement an action plan to improve the services they provide. In this period the GPhC agreed 469 action plans with pharmacies to ensure they improved the services they provide, and 99% of them made the necessary improvements so that they were meeting all of the standards. In the same period 140 cases were made affecting an individual pharmacy professional’s registration.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 123566 question first answered 23/01/2018 17:21:47 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

824572

registered interest
date	17/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Disclosure of Information
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Freedom to Speak up Guardians have been nominated in community pharmacies; and whether his Department holds information on names of those Guardians.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	123373
answer	answer is ministerial correction date of answer 22/01/2018 answer text <p>The Department does not hold information on the number or names of Freedom to Speak up Guardians in community pharmacies.</p><p> </p><p>NHS England is responsible for issuing the guidance on Freedom to Speak Up in primary care and has provided the following response:</p><p> </p><p>The number and names of Freedom to Speak Up Guardians in community pharmacies is not held centrally. Guidance for primary care providers was published in November 2016 on the NHS England website and a number of models for Freedom to Speak Up are detailed within that guidance, including having a named Guardian who is independent of the line management chain and not a direct employee. NHS England is working with the National Guardian's Office to assess the support that primary care providers, including community pharmacies, may need to comply with this guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/01/2018 17:23:23 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

819159

registered interest
date	09/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the take-up of the new enhanced influenza vaccine for the over-65s by (i) GPs and (ii) pharmacies in the 2017-18 and 2018-19 influenza seasons.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	121836
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The adjuvanted trivalent influenza vaccine was not available for use in 2017/18.</p><p> </p><p>General practitioners (GPs) and pharmacies are responsible for ordering and purchasing flu vaccines for the adult seasonal flu programme (eligible individuals aged 18 years and over) directly from manufacturers.</p><p> </p><p>Information on what vaccines are being ordered by these independent contractors is not routinely collected. Information on vaccines used by pharmacies and GPs will be available after the end of a flu season when practice/pharmacies claim reimbursement for the cost of the vaccines they have used.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:50:12 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

819160

registered interest
date	09/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to encourage the take-up of the new enhanced influenza vaccine for the over-65s for the 2018-19 influenza season with GPs and pharmacies.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	121837
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>Public Health England has updated their advice in the Green Book chapter on influenza so that clinicians are aware of the advice of the Joint Committee on Vaccination and Immunisation in relation to the adjuvanted trivalent influenza vaccine.</p><p> </p><p>In addition, NHS England wrote to general practitioners and clinical commissioning groups (via NHS England local teams) in December 2017 to provide an update on the use of the adjuvanted trivalent influenza vaccine for 2018/19.</p><p> </p><p>This update will also be made available to community pharmacies as part of confirming that the Advanced Influenza Vaccination service has been recommissioned in early 2018. Community pharmacies are able to order relevant vaccines as detailed in the service specification, including the enhanced vaccine for patients within the relevant cohort.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:47:39 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

819161

registered interest
date	09/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from (a) GPs, (b) patient organisations and (c) manufacturers on the availability of the new enhanced influenza vaccine for the over-65s for the 2017-18 and the 2018-19 season.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	121838
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>Officials at the Department and Public Health England have regular discussions with manufacturers on a range of issues. This has included discussion with Seqirus, the company that has produced the new adjuvanted trivalent flu vaccine (aTIV).</p><p> </p><p>Officials have had no discussions with general practitioner representatives or patient groups on the aTIV.</p><p> </p><p>Officials also attend meetings of the Joint Committee on Vaccination and Immunisation, which includes a lay member.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:51:33 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron